Brunswick (BC) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY26 Guidance
Get Alerts BC Hot Sheet
Price: $74.43 +2.30%
Revenue Growth %: +7.4%
Financial Fact:
Basic (in shares): 0.94
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +7.4%
Financial Fact:
Basic (in shares): 0.94
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Brunswick (NYSE: BC) reported Q4 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.21 billion.
GUIDANCE:
Brunswick sees FY2026 EPS of $3.80-$4.40, versus the consensus of $4.19. Brunswick sees FY2026 revenue of $5.6-5.8 billion, versus the consensus of $5.54 billion.
For earnings history and earnings-related data on Brunswick (BC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- RBC Capital Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Sector Perform
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share